We are looking for children 2 to 17 years old to join a clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderately to severely active IBD (including associated symptoms such as abdominal pain and cramps, blood in the stool, rectal pain, malnutrition and/or eye pain), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the CD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
